High IgG Anti-IgE Autoantibodies Prevent Early Omalizumab Response in Chronic Spontaneous Urticaria

被引：0
|
作者：
Niwa, Yusuke [1 ,2 ]
Hayama, Koremasa [1 ,2 ]
Toyoshima, Shota [3 ]
Shimizu, Keisuke [1 ,2 ]
Tagui, Maho [1 ,2 ]
Ito, Mana [1 ,2 ]
Sakamoto, Tomomi [2 ]
Terui, Tadashi [1 ,2 ]
Fujita, Hideki [1 ,2 ]
Okayama, Yoshimichi [2 ,4 ,5 ,6 ,7 ]
机构：
[1] Nihon Univ, Sch Med, Dept Dermatol, Div Cutaneous Sci, Tokyo, Japan
[2] Nihon Univ, Ctr Allergy, Sch Med, Tokyo, Japan
[3] Nippon Med Sch, Dept Biochem Mol Biol, Tokyo, Japan
[4] Misato Kenwa Hosp, Dept Allergy, Internal Med, Saitama, Japan
[5] Nihon Univ, Dept Med, Div Resp Med, Sch Med, Tokyo, Japan
[6] Showa Univ, Dept Internal Med, Div Resp Med & Allergol, Sch Med, Tokyo, Japan
[7] Gunma Paz Univ, Adv Med Sci Res Ctr, Grad Sch Hlth Sci, Takasaki, Gunma, Japan
来源：
ALLERGY | 2024年
关键词：
D O I：
10.1111/all.16419
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab
    Watanabe, Haruka
    Takahagi, Shunsuke
    Hayama, Koremasa
    Fukunaga, Atsushi
    Nakagawa, Yukinobu
    Inomata, Naoko
    Chinuki, Yuko
    Hide, Michihiro
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [42] Omalizumab treatment response in patients with chronic spontaneous urticaria
    Knezevic, Sandra
    Dujmovic-Hasanbegovic, Katarina
    Peternel, Sandra
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 377 - 378
  • [43] Baseline levels of the high-affinity IgE receptor on basophils are associated with the time to response to omalizumab in chronic spontaneous urticaria
    Gimenez-Arnau, A. M.
    Deza, G.
    Bertolin-Colilla, M.
    Pujol, R. M.
    Gimeno, R.
    ALLERGY, 2018, 73 : 223 - 223
  • [44] Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies to induce FcεRI crosslinking, as compared to anti-FcεRIα autoantibodies
    Izaki, S.
    Toyoshima, S.
    Endo, T.
    Hayama, K.
    Okayama, Y.
    Terui, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S217 - S217
  • [45] Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma
    Bousquet, J
    Wenzel, S
    Holgate, S
    Lumry, W
    Freeman, P
    Fox, H
    CHEST, 2004, 125 (04) : 1378 - 1386
  • [46] Anti-IgE for chronic urticaria - are children little adults after all?
    Wahn, Ulrich
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2015, 26 (06) : 488 - 489
  • [47] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MONOCLONAL ANTI-IGE ANTIBODY OMALIZUMAB IN THE MANAGEMENT OF PRURITUS IN CHRONIC SPONTANEOUS URTICARIA IN THE PEDIATRIC POPULATION
    Mitra, Barnali
    Vasudevan, Biju
    Solanki, Reema
    Mitra, Debdeep
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1016 - 1017
  • [48] A randomized, double-blind, placebo-controlled study of monoclonal Anti-IgE antibody Omalizumab in the management of pruritus in chronic spontaneous urticaria in the pediatric population
    Mitra, B.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 5 - 5
  • [49] Through the Looking Glass: Chronic Urticaria Treated with Anti-IgE Therapy
    Pajno, Giovanni B.
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2016, 29 (01) : 56 - 57
  • [50] High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies
    Millauer, N
    Zuercher, AW
    Miescher, SM
    Gerber, HA
    Seitz, M
    Stadler, BM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 115 (01): : 183 - 188
12345